Management of Hypoglycemia When Oral Intake Is Refused

Clinical Assessment

• A blood glucose level of 3.4 mmol/L (≈61 mg/dL) constitutes true hypoglycemia, although it is slightly above the neuroglycopenic symptom threshold of 2.7–2.8 mmol/L. 2

Guideline Recommendations

• The Endocrine Society recommends that urgent hypoglycemia be treated with oral carbohydrates when feasible; if oral intake is not feasible (e.g., patient refusal), parenteral glucagon or glucose should be administered. 1

Initial Parenteral Treatment

• The standard initial dose for intravenous glucose therapy is 25 g of dextrose (50 % dextrose solution). 1
• Parenteral treatment is indicated when a hypoglycemic patient is unwilling or unable to ingest carbohydrates orally. 1

Post‑Treatment Management

• Blood glucose should be monitored serially after IV glucose administration to detect rapid changes. 1
• Once the patient can safely ingest food, oral feeding should be provided promptly. 1
• If oral intake cannot be resumed, a subsequent glucose infusion should be considered. 1

Safety Considerations

• Clinicians should aim to avoid post‑treatment hyperglycemia, as rapid glucose reperfusion may contribute to neuronal injury in animal models. 1
• In cases where sulfonylurea overdose is suspected, prolonged hypoglycemia may occur; hospitalization for extended monitoring and treatment is advisable. 1